Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laparoscopic electrochemotherapy for locally advanced pancreatic cancer (phase IIb)
2018-003925-27Phase 2Active
- Sponsor
- Istituto Nazionale Tumori IRCCS Fondazione Pascale
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bleomycin in pancreatic cancer (PC) (2 arms), sponsored by Istituto Nazionale Tumori IRCCS Fondazione Pascale. Primary endpoint: Objective response rate of treated lesion. Started Dec 2018; status: active.
02
Drugs
bleomycin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on 2018-003925-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003925-27.